Park Ha Biological Technology Co., Ltd.
PHH
$0.4785
$0.00050.11%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 45.28% | 45.28% | 40.58% | 40.58% | -37.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 45.28% | 45.28% | 40.58% | 40.58% | -37.81% |
| Cost of Revenue | -40.33% | -40.33% | -47.74% | -47.74% | -21.44% |
| Gross Profit | 56.41% | 56.41% | 58.78% | 58.78% | -39.45% |
| SG&A Expenses | 3,148.79% | 3,148.79% | 86.76% | 86.76% | 15.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2,655.04% | 2,655.04% | 42.25% | 42.25% | 9.16% |
| Operating Income | -21,437.23% | -21,437.23% | 38.67% | 38.67% | -86.31% |
| Income Before Tax | -21,191.20% | -21,191.20% | 38.93% | 38.93% | -86.25% |
| Income Tax Expenses | 303.15% | 303.15% | 78.13% | 78.13% | -75.03% |
| Earnings from Continuing Operations | -40,581.63% | -40,581.63% | 21.98% | 21.98% | -90.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40,581.63% | -40,581.63% | 21.98% | 21.98% | -90.20% |
| EBIT | -21,437.23% | -21,437.23% | 38.67% | 38.67% | -86.31% |
| EBITDA | -19,115.44% | -19,115.44% | 38.19% | 38.19% | -84.87% |
| EPS Basic | -36,990.00% | -36,990.00% | 22.86% | 22.86% | -90.00% |
| Normalized Basic EPS | -19,141.67% | -19,141.67% | 39.68% | 39.68% | -85.88% |
| EPS Diluted | -36,990.00% | -36,990.00% | 22.86% | 22.86% | -90.00% |
| Normalized Diluted EPS | -19,141.67% | -19,141.67% | 39.68% | 39.68% | -85.88% |
| Average Basic Shares Outstanding | 7.55% | 7.55% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 7.55% | 7.55% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |